|
At the core of Nutrition 21, lies the belief that high
quality science and ground-breaking technology can lead to the
development of superior ingredients. The company’s scientific
platform is based upon our ability to create patentable
ingredients and products that have enhanced absorption and
bioavailability to produce safe and clinically efficacious
results. The company’s current product line targets conditions
associated with diabetes, obesity, metabolic syndrome,
cardiovascular health, arthritis, cognitive health, and immune
function. Poor nutrition can contribute to chronic conditions,
and Nutrition 21’s ingredients can be used in products that
provide consumers with the added nutrition they desire. The
Company’s lead ingredients include Chromax chromium picolinate,
Diachrome chromium picolinate + biotin, Selenomax high-selenium
yeast, Zinmax zinc picolinate and Probiomega probiotic.
Beginning in 1999, Nutrition 21 launched an ambitious research
program designed to bring pharmaceutical quality research to
develop a better understanding of the beneficial effects of the
trace mineral chromium, in the form of Chromax chromium
picolinate. Nutrition 21’s research program had uncovered what
may represent a fundamentally new appreciation of chromium--and
other nutrients such as biotin—and their interrelated roles in
complex metabolic and biochemical pathways linking diabetes,
cardiovascular health, obesity, depression, and other health
conditions. Chromax chromium picolinate is now the leader in the
chromium category because of chromium picolinate's enhanced
absorption and bioavailability, and the numerous quality
clinical studies supporting its safety and efficacy. Nutrition
21 also has a pipeline of new ingredients that will continue to
follow its tradition of science-based technology, providing
enhanced absorption and bioavailability, and the highest quality
that consumers and health care professionals can be confident
in.
|
 |